Stretch-induced regulation of angiotensinogen gene expression in cardiac myocytes and fibroblasts: Opposing roles of JNK1/2 and p38α MAP kinases

Journal of Molecular and Cellular Cardiology

Volumn 45, Issue 6, 2008, Pages 770-778

  Lal, Hind ^a   Verma, Suresh K ^a   Golden, Honey B ^a   Foster, Donald M ^b   Smith, Manuela ^a   Dostal, David E ^a  

^a TEXAS A AND M UNIVERSITY SYSTEM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiotensinogen; Cardiac fibroblasts; Cardiac myocytes; JNK; MAP kinases; Mechanical stretch; p38; Renin angiotensin system

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOTENSINOGEN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COMPLEMENTARY DNA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL LYSATE; CONTROLLED STUDY; ENZYME ACTIVATION; FIBROBLAST; GENE EXPRESSION REGULATION; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART VENTRICLE; MECHANICAL STRESS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VIRUS RECOMBINANT; WESTERN BLOTTING;

ANGIOTENSINOGEN; ANIMALS; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION REGULATION; HEART VENTRICLES; MITOGEN-ACTIVATED PROTEIN KINASE 14; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; MYOCARDIUM; MYOCYTES, CARDIAC; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; STRESS, PHYSIOLOGICAL; TIME FACTORS;

ADENOVIRIDAE; RATTUS;

EID: 55649105835     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.09.121     Document Type: Article

References (44)

1. Xu J., Carretero O.A., Lin C.X., Cavasin M.A., Shesely E.G., Yang J.J., et al. Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction. Am. J. Physiol. 293 3 (2007) H1900-H1907
2. Kumar R., Singh V.P., and Baker K.M. The intracellular renin-angiotensin system: implications in cardiovascular remodeling. Curr. Opin. Nephrol. Hypertens. 17 2 (2008) 168-173
3. Serneri G.G., Boddi M., Cecioni I., Vanni S., Coppo M., Papa M.L., et al. Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Circ. Res. 88 9 (2001) 961-968
4. Wollert K.C., and Drexler H. The renin-angiotensin system and experimental heart failure. Cardiovasc. Res. 43 4 (1999) 838-849
5. Jorde U.P. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact. Cardiol. Rev. 14 2 (2006) 81-87
6. Granger C.B., McMurray J.J., Yusuf S., Held P., Michelson E.L., Olofsson B., et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 362 9386 (2003) 772-776
7. Dostal D.E., and Baker K.M. The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?. Circ. Res. 85 7 (1999) 643-650
8. Zhang X., Dostal D.E., Reiss K., Cheng W., Kajstura J., Li P., et al. Identification and activation of autocrine renin-angiotensin system in adult ventricular myocytes. Am. J. Physiol. 269 5 Pt 2 (1995) H1791-H1802
9. Baker K.M., Booz G.W., and Dostal D.E. Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Annu. Rev. Physiol. 54 (1992) 227-241
10. Dostal D.E., Rothblum K.N., Chernin M.I., Cooper G.R., and Baker K.M. Intracardiac detection of angiotensinogen and renin: a localized renin-angiotensin system in neonatal rat heart. Am. J. Physiol. 263 4 Pt 1 (1992) C838-C850
11. Shivakumar K., Dostal D.E., Boheler K., Baker K.M., and Lakatta E.G. Differential response of cardiac fibroblasts from young adult and senescent rats to ANG II. Am. J. Physiol. 284 4 (2003) H1454-H1459
12. Xu J., Carretero O.A., Lin C.X., Cavasin M.A., Shesely E.G., Yang J.J., et al. Role of cardiac overexpression of angiotensin II in the regulation of cardiac function and remodeling post-myocardial infarction. Am. J. Physiol. 293 3 (2007) H1900-H1907
13. Liao P., Georgakopoulos D., Kovacs A., Zheng M., Lerner D., Pu H., et al. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc. Natl. Acad. Sci. U. S. A. 98 21 (2001) 12283-12288
14. Bassi R., Heads R., Marber M.S., and Clark J.E. Targeting p38-MAPK in the ischaemic heart: kill or cure?. Curr. Opin. Pharmacol. 8 2 (2008) 141-146
15. Liang Q., Bueno O.F., Wilkins B.J., Kuan C.Y., Xia Y., and Molkentin J.D. c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling. Embo. J. 22 19 (2003 (Oct 1)) 5079-5089
16. Chen Z., Gibson T.B., Robinson F., Silvestro L., Pearson G., Xu B., et al. MAP kinases. Chem. Rev. 101 8 (2001) 2449-2476
17. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 103 2 (2000) 239-252
18. Petrich B.G., and Wang Y. Stress-activated MAP kinases in cardiac remodeling and heart failure; new insights from transgenic studies. Trends. Cardiovasc. Med. 14 2 (2004) 50-55
19. Liang Q., and Molkentin J.D. Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. J. Mol. Cell. Cardiol. 35 12 (2003) 1385-1394
20. Nagy N., Shiroto K., Malik G., Huang C.K., Gaestel M., Abdellatif M., et al. Ischemic preconditioning involves dual cardio-protective axes with p38MAPK as upstream target. J. Mol. Cell. Cardiol. 42 5 (2007) 981-990
21. Wang Y. Mitogen-activated protein kinases in heart development and diseases. Circulation 116 12 (2007) 1413-1423
22. Park J.K., Fischer R., Dechend R., Shagdarsuren E., Gapeljuk A., Wellner M., et al. p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage. Hypertension 49 3 (2007) 481-489
23. Tachibana H., Perrino C., Takaoka H., Davis R.J., Naga Prasad S.V., and Rockman H.A. JNK1 is required to preserve cardiac function in the early response to pressure overload. Biochem. Biophys. Res. Commun. 343 4 (2006) 1060-1066
24. Sadoshima J., Montagne O., Wang Q., Yang G., Warden J., Liu J., et al. The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. J. Clin. Invest. 110 2 (2002) 271-279
25. Lal H., Verma S.K., Smith M., Guleria R.S., Lu G., Foster D.M., et al. Stretch-induced MAP kinase activation in cardiac myocytes: differential regulation through beta1-integrin and focal adhesion kinase. J. Mol. Cell. Cardiol. 43 2 (2007) 137-147
26. Fukuzawa J., Booz G.W., Hunt R.A., Shimizu N., Karoor V., Baker K.M., et al. Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3: an autocrine loop for hypertrophy. Hypertension 35 6 (2000) 1191-1196
27. Bader M. Role of the local renin-angiotensin system in cardiac damage: a minireview focussing on transgenic animal models. J. Mol. Cell. Cardiol. 34 11 (2002) 1455-1462
28. Palomeque J., Sapia L., Hajjar R.J., Mattiazzi A., and Vila Petroff M. Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK. Am. J. Physiol. 290 1 (2006) H96-H106
29. Mel'nikova N.P., Timoshin S.S., Jivotova E.Y., Pelliniemi L.J., Jokinen E., and Abdelwahid E. Angiotensin-II activates apoptosis, proliferation and protein synthesis in the left heart ventricle of newborn albino rats. Int. J. Cardiol. 112 2 (2006) 219-222
30. Dostal D.E., Rothblum K.C., Lin C.C., and Baker K.M. Regulation of renin and angiotensinogen in cultured neonatal rat cardiac fibroblasts by adrenergic, glucocorticoids, and angiotensin II stimulation. Hypertension 26 (1995) A562
31. Esposito G., Prasad S.V., Rapacciuolo A., Mao L., Koch W.J., and Rockman H.A. Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload. Circulation 103 10 (2001) 1453-1458
32. Roussel E., Gaudreau M., Plante E., Drolet M.C., Breault C., Couet J., et al. Early responses of the left ventricle to pressure overload in Wistar rats. Life sciences 82 5-6 (2008) 265-272
33. Wang Y., Su B., Sah V.P., Brown J.H., Han J., and Chien K.R. Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J. Biol. Chem. 273 10 (1998) 5423-5426
34. Choukroun G., Hajjar R., Fry S., del Monte F., Haq S., Guerrero J.L., et al. Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases. J. Clin. Invest. 104 4 (1999) 391-398
35. Kyoi S., Otani H., Matsuhisa S., Akita Y., Tatsumi K., Enoki C., et al. Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the cardiomyopathic hamster. Cardiovasc. Res. 69 4 (2006) 888-898
36. Domenighetti A.A., Wang Q., Egger M., Richards S.M., Pedrazzini T., and Delbridge L.M. Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure. Hypertension 46 2 (2005) 426-432
37. Kimura B., Mohuczy D., Tang X., and Phillips M.I. Attenuation of hypertension and heart hypertrophy by adeno-associated virus delivering angiotensinogen antisense. Hypertension 37 2 Part 2 (2001) 376-380
38. Sanghi S., Kumar R., Smith M., Baker K.M., and Dostal D.E. Activation of protein kinase A by atrial natriuretic peptide in neonatal rat cardiac fibroblasts: role in regulation of the local renin-angiotensin system. Regul. Pept. 132 1-3 (2005) 1-8
39. Dostal D.E., Booz G.W., and Baker K.M. Regulation of angiotensinogen gene expression and protein in neonatal rat cardiac fibroblasts by glucocorticoid and beta-adrenergic stimulation. Basic. Res. Cardiol. 95 6 (2000) 485-490
40. Booz G.W., Dostal D.E., and Baker K.M. Paracrine actions of cardiac fibroblasts on cardiomyocytes: implications for the cardiac renin-angiotensin system. Am. J. Cardiol. 83 12A (1999) 44H-47H
41. Lal H., Guleria R.S., Foster D.M., Lu G., Watson L.E., Sanghi S., et al. Integrins: novel therapeutic targets for cardiovascular diseases. Cardiovasc. Hematol. Agents. Med. Chem. 5 2 (2007) 109-132
42. Sabri A., and Lucchesi P.A. ANG II and cardiac myocyte contractility: p38 is not stressed out!. Am. J. Physiol. 290 1 (2006) H72-H73
43. Hsieh T.J., Fustier P., Zhang S.L., Filep J.G., Tang S.S., Ingelfinger J.R., et al. High glucose stimulates angiotensinogen gene expression and cell hypertrophy via activation of the hexosamine biosynthesis pathway in rat kidney proximal tubular cells. Endocrinology 144 10 (2003) 4338-4349
44. Narayanan C.S., Cui Y., Kumar S., and Kumar A. cAMP increases the expression of human angiotensinogen gene through a combination of cyclic AMP responsive element binding protein and a liver specific transcription factor. Mol. Cell. Biochem. 212 1-2 (2000) 81-90